{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T13:24:29Z","timestamp":1794230669951,"version":"4.9.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018836","name":"Alzheimer's Research & Prevention Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018836","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001024","name":"Roy J Carver Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Metabolism"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.molmet.2026.102458","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:24:18Z","timestamp":1792106658000},"page":"102458","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Hyperactive mTORC1 underlies sex dimorphic progression of MASLD in mice with hepatocyte prohibitin-1 deficiency"],"prefix":"10.1016","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2520-3288","authenticated-orcid":false,"given":"Amany A.","family":"Alowaisi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolonda C.","family":"Mahoney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5465-9834","authenticated-orcid":false,"given":"Ran","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Islam A.","family":"Berdaweel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7602-0663","authenticated-orcid":false,"given":"Rachel M.","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kendall J.","family":"Mallaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1002-5872","authenticated-orcid":false,"given":"Jared M.","family":"McLendon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0113-8875","authenticated-orcid":false,"given":"Ethan J.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.molmet.2026.102458_bib1","first-page":"1372","article-title":"Prohibitin, an evolutionarily conserved intracellular protein that blocks DNA synthesis in normal fibroblasts and HeLa cells","volume":"11","author":"Nuell","year":"1991","journal-title":"Mol Cell Biol"},{"issue":"1","key":"10.1016\/j.molmet.2026.102458_bib2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.mito.2010.07.002","article-title":"Nuclear coded mitochondrial protein prohibitin is an iron regulated iron binding protein","volume":"11","author":"Ande","year":"2011","journal-title":"Mitochondrion"},{"issue":"5","key":"10.1016\/j.molmet.2026.102458_bib3","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/1535370220908257","article-title":"Prohibitin 1 in liver injury and cancer","volume":"245","author":"Barbier-Torres","year":"2020","journal-title":"Exp Biol Med (Maywood)"},{"issue":"2","key":"10.1016\/j.molmet.2026.102458_bib4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1582-4934.2006.tb00404.x","article-title":"The prohibitins: emerging roles in diverse functions","volume":"10","author":"Mishra","year":"2006","journal-title":"J Cell Mol Med"},{"issue":"1","key":"10.1016\/j.molmet.2026.102458_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/cells8010071","article-title":"Prohibitins: a critical role in mitochondrial functions and implication in diseases","volume":"8","author":"Signorile","year":"2019","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.molmet.2026.102458_bib6","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.bbamcr.2011.01.033","article-title":"The role and therapeutic potential of prohibitin in disease","volume":"1813","author":"Theiss","year":"2011","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"10.1016\/j.molmet.2026.102458_bib7","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1128\/MCB.19.5.3435","article-title":"Prohibitins regulate membrane protein degradation by the m-AAA protease in mitochondria","volume":"19","author":"Steglich","year":"1999","journal-title":"Mol Cell Biol"},{"issue":"11","key":"10.1016\/j.molmet.2026.102458_bib8","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1093\/emboj\/19.11.2444","article-title":"Prohibitins act as a membrane-bound chaperone for the stabilization of mitochondrial proteins","volume":"19","author":"Nijtmans","year":"2000","journal-title":"EMBO J"},{"issue":"40","key":"10.1016\/j.molmet.2026.102458_bib9","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.L119.010788","article-title":"Phb1:Phb2 heterodimers in the mitochondria-beyond functional interdependence","volume":"294","author":"Mishra","year":"2019","journal-title":"J Biol Chem"},{"issue":"18","key":"10.1016\/j.molmet.2026.102458_bib10","doi-asserted-by":"crossref","first-page":"5783","DOI":"10.1016\/j.jprot.2012.08.009","article-title":"Prohibitin-1 deficiency promotes inflammation and increases sensitivity to liver injury","volume":"75","author":"Sanchez-Quiles","year":"2012","journal-title":"J Proteonomics"},{"issue":"6","key":"10.1016\/j.molmet.2026.102458_bib11","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1002\/hep.23919","article-title":"Liver-specific deletion of prohibitin 1 results in spontaneous liver injury, fibrosis, and hepatocellular carcinoma in mice","volume":"52","author":"Ko","year":"2010","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.molmet.2026.102458_bib12","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1073\/pnas.0536625100","article-title":"Functional proteomics of nonalcoholic steatohepatitis: mitochondrial proteins as targets of S-adenosylmethionine","volume":"100","author":"Santamaria","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.molmet.2026.102458_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106293","article-title":"Activation of AMP-activated protein kinase (AMPK) through inhibiting interaction with prohibitins","volume":"26","author":"Kanagaki","year":"2023","journal-title":"iScience"},{"issue":"3","key":"10.1016\/j.molmet.2026.102458_bib14","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s11684-020-0805-6","article-title":"Prohibitin regulates mTOR pathway via interaction with FKBP8","volume":"15","author":"Zhang","year":"2021","journal-title":"Front Med"},{"issue":"2","key":"10.1016\/j.molmet.2026.102458_bib15","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1039\/D0FO02501A","article-title":"Berbamine induced activation of the SIRT1\/LKB1\/AMPK signaling axis attenuates the development of hepatic steatosis in high-fat diet-induced NAFLD rats","volume":"12","author":"Sharma","year":"2021","journal-title":"Food Funct"},{"issue":"2","key":"10.1016\/j.molmet.2026.102458_bib16","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.molcel.2008.03.003","article-title":"AMPK phosphorylation of raptor mediates a metabolic checkpoint","volume":"30","author":"Gwinn","year":"2008","journal-title":"Mol Cell"},{"issue":"2","key":"10.1016\/j.molmet.2026.102458_bib17","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cell.2017.03.035","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"169","author":"Saxton","year":"2017","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.molmet.2026.102458_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19072043","article-title":"Role of mTOR in glucose and lipid metabolism","volume":"19","author":"Mao","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.molmet.2026.102458_bib19","article-title":"Research progress on AMPK in the pathogenesis and treatment of MASLD","volume":"16","author":"Feng","year":"2025","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.molmet.2026.102458_bib20","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1111\/jgh.16272","article-title":"AMPK\/mTOR pathway significance in healthy liver and non-alcoholic fatty liver disease and its progression","volume":"38","author":"Marcondes-de-Castro","year":"2023","journal-title":"J Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.molmet.2026.102458_bib21","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.179990","article-title":"AMPK activator ATX-304 reduces oxidative stress and improves MASLD via metabolic switching","volume":"10","author":"Holm","year":"2025","journal-title":"JCI Insight"},{"key":"10.1016\/j.molmet.2026.102458_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2025.120246","article-title":"Zhuru extracts ameliorate lipid accumulation of MASLD via suppressing the mTORC1\/SREBPs pathway","volume":"352","author":"Sun","year":"2025","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.molmet.2026.102458_bib23","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.66278","article-title":"Activation of mTORC1 and c-Jun by Prohibitin1 loss in Schwann cells may link mitochondrial dysfunction to demyelination","volume":"10","author":"Della-Flora Nunes","year":"2021","journal-title":"eLife"},{"issue":"3","key":"10.1016\/j.molmet.2026.102458_bib24","doi-asserted-by":"crossref","first-page":"275","DOI":"10.15252\/emmm.201404916","article-title":"Inhibition of insulin\/IGF-1 receptor signaling protects from mitochondria-mediated kidney failure","volume":"7","author":"Ising","year":"2015","journal-title":"EMBO Mol Med"},{"issue":"1","key":"10.1016\/j.molmet.2026.102458_bib25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13293-018-0196-4","article-title":"Gonadectomy in Mito-Ob mice revealed a sex-dimorphic relationship between prohibitin and sex steroids in adipose tissue biology and glucose homeostasis","volume":"9","author":"Xu","year":"2018","journal-title":"Biol Sex Differ"},{"issue":"5","key":"10.1016\/j.molmet.2026.102458_bib26","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1210\/er.2019-00034","article-title":"The liver as an endocrine organ-linking NAFLD and insulin resistance","volume":"40","author":"Watt","year":"2019","journal-title":"Endocr Rev"},{"key":"10.1016\/j.molmet.2026.102458_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101596","article-title":"Mouse tissue harvest-induced hypoxia rapidly alters the in vivo metabolome, between-genotype metabolite level differences, and (13)C-tracing enrichments","volume":"66","author":"Rauckhorst","year":"2022","journal-title":"Mol Metabol"},{"issue":"2","key":"10.1016\/j.molmet.2026.102458_bib28","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/alcalc\/agu102","article-title":"The role of lipin-1 in the pathogenesis of alcoholic fatty liver","volume":"50","author":"Bi","year":"2015","journal-title":"Alcohol Alcohol"},{"issue":"3","key":"10.1016\/j.molmet.2026.102458_bib29","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.cell.2011.06.034","article-title":"mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway","volume":"146","author":"Peterson","year":"2011","journal-title":"Cell"},{"issue":"460","key":"10.1016\/j.molmet.2026.102458_bib30","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aah4117","article-title":"The SCFbeta-TRCP E3 ubiquitin ligase complex targets Lipin1 for ubiquitination and degradation to promote hepatic lipogenesis","volume":"10","author":"Shimizu","year":"2017","journal-title":"Sci Signal"},{"issue":"14","key":"10.1016\/j.molmet.2026.102458_bib31","doi-asserted-by":"crossref","first-page":"9933","DOI":"10.1074\/jbc.M112.441493","article-title":"Phosphorylation of lipin 1 and charge on the phosphatidic acid head group control its phosphatidic acid phosphatase activity and membrane association","volume":"288","author":"Eaton","year":"2013","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.molmet.2026.102458_bib32","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.cgh.2024.03.006","article-title":"The global epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among patients with type 2 diabetes","volume":"22","author":"Younossi","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.molmet.2026.102458_bib33","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jceh.2022.12.005","article-title":"The growing economic and clinical burden of nonalcoholic steatohepatitis (NASH) in the United States","volume":"13","author":"Younossi","year":"2023","journal-title":"J Clin Exp Hepatol"},{"issue":"9","key":"10.1016\/j.molmet.2026.102458_bib34","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41575-021-00448-y","article-title":"The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments","volume":"18","author":"Targher","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.molmet.2026.102458_bib35","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/gutjnl-2023-330595","article-title":"MASLD: a systemic metabolic disorder with cardiovascular and malignant complications","volume":"73","author":"Targher","year":"2024","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.molmet.2026.102458_bib36","article-title":"Vitamin E and pioglitazone: a comprehensive systematic review of their efficacy in non-alcoholic fatty liver disease","volume":"15","author":"Mazhar","year":"2023","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.molmet.2026.102458_bib37","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1053\/j.gastro.2013.05.042","article-title":"Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease","volume":"145","author":"Mudaliar","year":"2013","journal-title":"Gastroenterology"},{"issue":"17","key":"10.1016\/j.molmet.2026.102458_bib38","first-page":"1439","article-title":"FDA okays first drug for scarring from fatty liver disease","volume":"331","author":"Harris","year":"2024","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.molmet.2026.102458_bib39","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v31.i4.99312","article-title":"Elafibranor, a dual PPARalpha and PPARdelta agonist, reduces alcohol-associated liver disease: lessons from a mouse model","volume":"31","author":"Pirola","year":"2025","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.molmet.2026.102458_bib40","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/s12935-022-02765-x","article-title":"The function of prohibitins in mitochondria and the clinical potentials","volume":"22","author":"Oyang","year":"2022","journal-title":"Cancer Cell Int"},{"issue":"3","key":"10.1016\/j.molmet.2026.102458_bib41","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/gut.2005.071118","article-title":"Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice","volume":"55","author":"Tomita","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.molmet.2026.102458_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.717911","article-title":"RNA-seq reveals different gene expression in liver-specific prohibitin 1 knock-out mice","volume":"12","author":"Lee","year":"2021","journal-title":"Front Physiol"},{"issue":"5","key":"10.1016\/j.molmet.2026.102458_bib43","doi-asserted-by":"crossref","first-page":"539","DOI":"10.24272\/j.issn.2095-8137.2020.051","article-title":"Assessment of mitochondrial function in metabolic dysfunction-associated fatty liver disease using obese mouse models","volume":"41","author":"Zhao","year":"2020","journal-title":"Zool Res"},{"issue":"10","key":"10.1016\/j.molmet.2026.102458_bib44","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1248\/bpb.b16-00353","article-title":"Liver-specific silencing of Lipin1 reduces fat mass as well as hepatic triglyceride biosynthesis in mice","volume":"39","author":"Kajimoto","year":"2016","journal-title":"Biol Pharm Bull"},{"issue":"6","key":"10.1016\/j.molmet.2026.102458_bib45","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1074\/jbc.M109.072488","article-title":"Insulin-stimulated interaction with 14-3-3 promotes cytoplasmic localization of lipin-1 in adipocytes","volume":"285","author":"Peterfy","year":"2010","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.molmet.2026.102458_bib46","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1210\/en.2006-1728","article-title":"Lipin1 regulation by estrogen in uterus and liver: implications for diabetes and fertility","volume":"148","author":"Gowri","year":"2007","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.molmet.2026.102458_bib47","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13293-019-0239-5","article-title":"Prohibitin: a prime candidate for a pleiotropic effector that mediates sex differences in obesity, insulin resistance, and metabolic dysregulation","volume":"10","author":"Xu","year":"2019","journal-title":"Biol Sex Differ"},{"issue":"11","key":"10.1016\/j.molmet.2026.102458_bib48","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.2337\/db13-1807","article-title":"Prohibitin overexpression in adipocytes induces mitochondrial biogenesis, leads to obesity development, and affects glucose homeostasis in a sex-specific manner","volume":"63","author":"Ande","year":"2014","journal-title":"Diabetes"},{"issue":"1\u20132","key":"10.1016\/j.molmet.2026.102458_bib49","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s11010-015-2468-1","article-title":"Effect of estrogen on expression of prohibitin in white adipose tissue and liver of diet-induced obese rats","volume":"407","author":"Choi","year":"2015","journal-title":"Mol Cell Biochem"},{"issue":"2","key":"10.1016\/j.molmet.2026.102458_bib50","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s12257-016-0249-7","article-title":"Prohibitin deficiency causes opposing lipid metabolism between 3T3-L1 adipocytes and Clone 9 hepatocytes","volume":"21","author":"Choi","year":"2016","journal-title":"Biotechnol Bioproc Eng"},{"issue":"34","key":"10.1016\/j.molmet.2026.102458_bib51","doi-asserted-by":"crossref","first-page":"12581","DOI":"10.1074\/jbc.RA119.007601","article-title":"In vivo stabilization of OPA1 in hepatocytes potentiates mitochondrial respiration and gluconeogenesis in a prohibitin-dependent way","volume":"294","author":"Li","year":"2019","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.molmet.2026.102458_bib52","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nbt.3519","article-title":"Near-optimal probabilistic RNA-seq quantification","volume":"34","author":"Bray","year":"2016","journal-title":"Nat Biotechnol"},{"issue":"7","key":"10.1016\/j.molmet.2026.102458_bib53","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/nmeth.4324","article-title":"Differential analysis of RNA-seq incorporating quantification uncertainty","volume":"14","author":"Pimentel","year":"2017","journal-title":"Nat Methods"},{"issue":"1","key":"10.1016\/j.molmet.2026.102458_bib54","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-76603-3","article-title":"VolcaNoseR is a web app for creating, exploring, labeling and sharing volcano plots","volume":"10","author":"Goedhart","year":"2020","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.molmet.2026.102458_bib55","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.cels.2018.10.007","article-title":"BioJupies: automated generation of interactive notebooks for RNA-seq data analysis in the cloud","volume":"7","author":"Torre","year":"2018","journal-title":"Cell Syst"},{"issue":"6","key":"10.1016\/j.molmet.2026.102458_bib56","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.molmet.2015.04.001","article-title":"Obesity in a model of gpx4 haploinsufficiency uncovers a causal role for lipid-derived aldehydes in human metabolic disease and cardiomyopathy","volume":"4","author":"Katunga","year":"2015","journal-title":"Mol Metabol"}],"container-title":["Molecular Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877826001420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877826001420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T12:26:20Z","timestamp":1794227180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212877826001420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":56,"alternative-id":["S2212877826001420"],"URL":"https:\/\/doi.org\/10.1016\/j.molmet.2026.102458","relation":{},"ISSN":["2212-8778"],"issn-type":[{"value":"2212-8778","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperactive mTORC1 underlies sex dimorphic progression of MASLD in mice with hepatocyte prohibitin-1 deficiency","name":"articletitle","label":"Article Title"},{"value":"Molecular Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmet.2026.102458","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"102458"}}